Atara Biotherapeutics, Inc.
ATRA
Last
$9.48
Day
+2.7%
1y
-42.6%
5y
-97.9%
52w
-51.8%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1131d
EMA 21
9.15
EMA 50
9.12
EMA 200
9.06
20d high
-11.0%
5y high
-98.2%
5y range
1th
Positions held
Your positionsATRA isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
42
Hold
swing
Signal
Strong Buy
Target
$11.35
Stop
$8.17
Stop distance
13.8%
Target vs last
+19.7%
Fundamentals
| Market cap | $92.65M | Enterprise value | $92.65M | Trailing P/E | — | Forward P/E | 5.97 |
| PEG | — | Price / book | -2.36 | Beta | 0.22 | Dividend yield | 0.00% |
| Revenue growth | -96.4% | Earnings growth | — | Gross margin | 75.3% | Operating margin | -6.3% |
| Profit margin | -2.7% | ROE | — | ROA | -24.1% | Debt / equity | — |
| Current ratio | 1.98 | Free cash flow | -$12.52M | Analyst recommendation | buy | Mean target | $13.67 |
| 52w high | $19.15 | 52w low | $3.92 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.6M | $0.5M | $1.6M | $3.5M | $17.6M | — |
| Op margin | -749.2% | -652.9% | -160.7% | -103.5% | 18.2% | — |
| Net income | -$4.8M | -$4.1M | -$3.4M | -$4.3M | $2.4M | — |
| Gross margin | 69.7% | 76.0% | 93.5% | 96.7% | 96.8% | — |
| Gross profit | $0.4M | $0.4M | $1.5M | $3.3M | $17.0M | — |
| Operating income | -$4.7M | -$3.4M | -$2.6M | -$3.6M | $3.2M | — |
- Revenue +22% vs prior quarter ($0.6M vs $0.5M).
- Gross margin 69.7% (was 76% prior quarter).
- Operating margin compressed to -749.2%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $121M | $129M | $8.6M | $63.6M | — |
| Op margin | 29.7% | -64.7% | -3219.5% | -441.2% | — |
| Net income | $32.7M | -$85.4M | -$276M | -$228M | — |
| Gross margin | 82.4% | 83.7% | -3.7% | 100.0% | — |
| Gross profit | $99.6M | $108M | -$0.3M | $63.6M | — |
| Operating income | $35.9M | -$83.4M | -$276M | -$281M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsATRA · daily-1.6% over 14 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin